JPRN-UMIN000033071
Recruiting
未知
Clinical efficacy and safety of a trans-cranial ultrasound apparatus LD-1 in the treatment of patients with mild Alzheimer's disease - Ultrasound therapy for mild Alzheimer's disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Alzheimer'
- Sponsor
- Tohoku University
- Enrollment
- 45
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who do not conflict with any of the following are included. 1\. Patients who are determined by investigators to be difficult to keep receiving the 20 minutes treatment. 2\. Patients who are determined by investigators to be difficult to perform MRI examination. 3\. Patients who have consciousness disorder with less than 12 points in GCS score. 4\. Diagnosed as symptomatic cerebral infarction or cerebral hemorrhage within 12 weeks before enrollment. 5\. Diagnosed as more than 5 points with Modified Hachinski Ischemic Scale. 6\. Diagnosed more than 4 spots of microhemorrhages by cranial MRI examination. 7\. Patients who are determined by investigators to be difficult to participate in the trial because of the severe mental disorder. 8\. Patients who are determined by investigators to be difficult to participate in the trial because of severe systemic disease (heart failure, liver failure, renal failure, etc.). 9\. Diagnosed as diabetic retinopathy with active fundus bleeding. 10\. Diagnosed malignant tumor at the time of enrollment or had been treated for malignant tumor within 5 years before enrollment. 11\. Diagnosed as drug addiction, alcoholism or having its previous history. 12\. Diagnosed as epilepsy or having its previous history. 13\. Patients who have artificial objects embedded in the cranium (coils, electrodes, etc.). 14\. Patients who have past history of brain surgery (including endovascular treatment). 15\. Patients who are planning pregnant. 16\. Patients who have already participating in other clinical trials. 17\. Patients who are determined by investigators to be inadequate to participate in the trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Effects of transcranial direct current electrical stimulation on major depressive disorderJPRN-jRCTs052220086Omori M Ichiro10
Recruiting
Not Applicable
An Exploratory Clinical Study for Verifying the Treatment Efficacy of Noninvasive Ultrasound Stimulation System for DepressioKCT0004102Yonsei University Health System, Gangnam Severance Hospital60
Completed
Not Applicable
Clinical effectiveness of repetitve transcranial magnetic stimulation (rTMS) as an adjunctive therapy in depression - a catchment area-based randomised controlled trialMajor depressive disorderMental and Behavioural DisordersDepressionISRCTN70121208South London and Maudsley NHS Trust (UK)54
Recruiting
Not Applicable
The safety and efficacy of repetitive transcranial magnetic stimulation on eating behaviors and body weight in obesity: A randomized, single-center, single blinded, parallel design, placebo-controlled studyKCT0002548The Catholic University of Korea, St. Vincent's Hospital40
Not yet recruiting
Not Applicable
Effectiveness of Transcranial Direct Current Stimulation (A brain stimulation technique) in treatment of Obsessive Compulsive Disorder.CTRI/2018/02/011845Department of Psychiatry